Related Experiment Video
Updated: Aug 7, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy
N D Hawkes1, G A Thomas, A Jurewicz
1Department of Gastroenterology, University Hospital of Wales, Heath Park, Cardiff, UK. neihawkes@doctors.org.uk
Abstract:
The clinical syndrome of encephalopathy is most often encountered in the context of decompensated liver disease and the diagnosis is usually clear cut. Non-hepatic causes of encephalopathy are rarer and tend to present to a wide range of medical specialties with variable and episodic symptoms. Delay can result in the development of potentially life threatening complications, such as seizures and coma. Early recognition is vital. A history of similar episodes or clinical risk factors and early assessment of blood ammonia levels help establish the diagnosis. In addition to adequate supportive care, investigation of the underlying cause of the hyperammonaemia is essential and its reversal, where possible, will often result in complete recovery. Detection of an unborn error of metabolism should lead to the initiation of appropriate maintenance therapy and genetic counselling.
Related Concept Videos
Urea Cycle
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Inborn Errors of Metabolism
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy

